Jaffetilchin Investment Partners’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-9,293
| Closed | -$325K | – | 399 |
|
|
2021
Q2 | $325K | Buy |
+9,293
| New | +$325K | 0.02% | 313 |
|
|
2021
Q1 | – | Sell |
-9,293
| Closed | -$325K | – | 377 |
|
|
2020
Q4 | $325K | Buy |
9,293
+3,791
| +69% | +$133K | 0.05% | 216 |
|
|
2020
Q3 | $132K | Buy |
5,502
+3,098
| +129% | +$74.3K | 0.02% | 217 |
|
|
2020
Q2 | $44K | Buy |
+2,404
| New | +$44K | 0.01% | 200 |
|
|
2019
Q3 | – | Sell |
-4,131
| Closed | -$108K | – | 259 |
|
|
2019
Q2 | $108K | Buy |
+4,131
| New | +$108K | 0.03% | 253 |
|